Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0%

0 of 8 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT04125017Not ApplicableCompleted

Atrificial Shrinkage of Blastocyst Before In Vitro Fertilization

Role: collaborator

NCT02397551Phase 4Completed

Three Small Doses of HCG Versus Booster Dose of HCG on Ovum Pickup Day

Role: collaborator

NCT02397642Not ApplicableCompleted

Dual Trigger Versus Booster Dose of HCG

Role: collaborator

NCT03038659Completed

Role of Intima-media Thickness in Determining Arteriogenic Erectile Dysfunction

Role: lead

NCT03033563Completed

ICSI Outcome of Ejaculated Versus Extracted Testicular Spermatozoa

Role: lead

NCT03033537Completed

Intracavernosal Injection of Papaverine/Verapamil Versus Papaverine/Phentolamine in Erectile Dysfunction

Role: lead

NCT03033082Completed

Evaluation of Marital and Sexual Satisfaction of Wives to Erectile Dysfunction Males

Role: lead

NCT01793272Not ApplicableCompleted

Beneficial Effect of Adding Pentoxifylline to Processed Semen Samples on ICSI Outcome in Infertile Males

Role: lead

All 8 trials loaded